Vida Ventures

Vida Ventures

Latest investments Show all
Undisclosed funding
Allogene Therapeutics
$62,000,000
Venture capital (Series B)
Pionyr Immunotherapeutics
Team Size
1–10
Employees
Past year's investments

Vida Ventures participated in fewer than 3 rounds over the past year

Latest rounds
  • Allogene Therapeutics: Undisclosed funding (Undisclosed amount)
  • Pionyr Immunotherapeutics: Venture capital (Series B) ($62M)
  • Homology Medicines: Venture capital (Series B) ($83.5M)